CT News and Research RSS Feed - CT News and Research

Study estimates Medicare costs of lung cancer diagnostic workup in patients

Study estimates Medicare costs of lung cancer diagnostic workup in patients

Biopsies were found to be the most costly tool prescribed in lung cancer diagnosis, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology. [More]
Group encourages approval of lung cancer screening for eligible Medicare patients

Group encourages approval of lung cancer screening for eligible Medicare patients

As the Centers for Medicare & Medicaid Services Committee on Coverage studies the decision to cover lung cancer screening for eligible individuals, today's Online First section of the journal CHEST published Components for High Quality Lung Cancer Screening: American College of Chest Physicians and American Thoracic Society Policy Statement. [More]
Krembil researchers potentially discover major cause of dementia

Krembil researchers potentially discover major cause of dementia

Researchers at the Krembil Neuroscience Centre have potentially discovered a major cause of dementia. In this type of dementia, there is damage to the white matter (nerve fibres) of the brain apparent on computerized tomography (CT) and magnetic resonance imaging (MRI) scans of older individuals. [More]
Primary care providers recommend LDCT screening for high-risk lung cancer patients

Primary care providers recommend LDCT screening for high-risk lung cancer patients

Patients at high-risk for developing lung cancer are more likely to receive low-dose computed tomography (LDCT) screening when their primary care provider is familiar with guideline recommendations for LDCT screening for lung cancer, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology. [More]
FDA recommens approval of Daiichi Sankyo's once-daily SAVAYSA for patients with NVAF

FDA recommens approval of Daiichi Sankyo's once-daily SAVAYSA for patients with NVAF

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee voted 9 to 1 to recommend approval of once-daily SAVAYSA (edoxaban) 60 mg dosing regimen for the reduction in risk of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation (NVAF). [More]
Endemic lung infection compromises lung cancer diagnosis

Endemic lung infection compromises lung cancer diagnosis

The accuracy of lung cancer diagnosis using 18F-fluorodeoxyglucose–positron emission tomography may be compromised in areas with endemic infectious lung diseases, research suggests. [More]
UT Southwestern Medical Center unveils new $800 million hospital

UT Southwestern Medical Center unveils new $800 million hospital

UT Southwestern Medical Center will unveil its new $800 million hospital at a dedication ceremony today. The 12-floor, 460-bed facility is being hailed as a patient-centered, state-of-the-art medical innovation for the people of Dallas, North Texas, and beyond. [More]
U-M researcher wins AGA-Covidien Research & Development Pilot Award in Technology

U-M researcher wins AGA-Covidien Research & Development Pilot Award in Technology

The American Gastroenterological Association Research Foundation is pleased to announce that Richard S. Kwon, MD, MS, from the University of Michigan, is the recipient of the inaugural AGA-Covidien Research & Development Pilot Award in Technology. This award is supported by a generous grant from Covidien, a leading global provider of health-care products. [More]
GE Healthcare’s advances in imaging quantitation may help clinicians diagnose disease earlier

GE Healthcare’s advances in imaging quantitation may help clinicians diagnose disease earlier

GE Healthcare shares a suite of advances in imaging quantitation that may help clinicians diagnose disease earlier, deliver more personalised treatment and speed up care at the 27th annual meeting of the European Association of Nuclear Medicine (EANM), 18-22 October, in Gothenburg. [More]
Renewal wrinkles, high deductibles and decisions for employers: These and other health law implementation issues grab headlines

Renewal wrinkles, high deductibles and decisions for employers: These and other health law implementation issues grab headlines

News outlets report on a range of health law implementation issues that are causing challenges for consumers, employers and Obamacare advocates. [More]
Administration's handling of Ebola casts shadow on Democrats' House and Senate hopes

Administration's handling of Ebola casts shadow on Democrats' House and Senate hopes

A Politico poll underscores that Ebola is causing real political danger for some Democrats. It's playing big, for instance, in North Carolina's Senate race. [More]
New preclinical imaging product line launched by MILabs at the 2014 Annual European Association of Nuclear Medicine Meeting

New preclinical imaging product line launched by MILabs at the 2014 Annual European Association of Nuclear Medicine Meeting

MILabs BV has launched a complete new preclinical product line at the 2014 Annual European Association of Nuclear Medicine Meeting in Gothenburg, Sweden, October 18-22 (www.eanm.org). It consists of the new 4-series comprising U-SPECT4, U-SPECT4CT, VECTor4 and VECTor4CT incorporating significant improvements over the former PLUS-series. The 4-series carries even further the tradition of MILabs to deliver the best SPECT and PET image resolution available in the market. [More]
Mediso launches MultiScan LFER 150 PET/CT for research applications

Mediso launches MultiScan LFER 150 PET/CT for research applications

Mediso announces the MultiScan LFER 150 PET/CT, the first member of the MultiScan product line dedicated to research applications for both clinical and pre-clinical imaging. The LFER 150 (Large Field of view Extreme Resolution) with 20 cm axial and 15 cm transaxial field of view (FOV), sub-mm PET resolution and 5% sensitivity is aimed at pre-clinical brain research. [More]
Cell transplantation treatment may benefit people with spinal cord injury

Cell transplantation treatment may benefit people with spinal cord injury

Two studies recently published in Cell Transplantation reveal that cell transplantation may be an effective treatment for spinal cord injury (SCI), a major cause of disability and paralysis with no current restorative therapies. [More]
New study reviews modern treatment modalities for early-stage lung cancer

New study reviews modern treatment modalities for early-stage lung cancer

Removal of the entire lobe of lung may offer patients with early-stage lung cancer better overall survival when compared with a partial resection, and stereotactic ablative radiotherapy (SABR) may offer the same survival benefit as a lobectomy for some patients, according to a study from The University of Texas MD Anderson Cancer Center. [More]
Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF). [More]
Kenneth Rainin Foundation grants $2.2 million for Inflammatory Bowel Disease research

Kenneth Rainin Foundation grants $2.2 million for Inflammatory Bowel Disease research

The Kenneth Rainin Foundation announced today that it will grant $2.2 million to scientists to conduct Inflammatory Bowel Disease (IBD) research. The Rainin Foundation offers support for cutting-edge projects that typically are not eligible for funding from more traditional sources due to their ground-breaking, pioneering nature. [More]
Multi-center study compares clinical performance of AAA procedures in virtual environment

Multi-center study compares clinical performance of AAA procedures in virtual environment

University Hospitals (UH) Case Medical Center and Simbionix recently launched a multi-center, randomized study comparing the clinical performance of abdominal aortic aneurysm (AAA) procedures with and without prior rehearsal in a virtual environment for physicians. [More]
State highlights: Blue Cross Blue Shield dominant in Texas

State highlights: Blue Cross Blue Shield dominant in Texas

A selection of health policy stories from Texas, New Jersey, Connecticut, Georgia, Missouri and New Mexico. [More]
NCCN publishes 20th annual editions of NCCN Guidelines for Colon and Rectal Cancers

NCCN publishes 20th annual editions of NCCN Guidelines for Colon and Rectal Cancers

The National Comprehensive Cancer Network has published the 20th annual editions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon and Rectal Cancers, two of the eight original NCCN Guidelines published in November 1996. [More]